According to a release issued by Aurobindo Pharma to the BSE today, Zidovudine oral solution is the first oral solution approval for the company.
"Zidovudine helps prevent the AIDS virus from reproducing in the body. It will be used with other antiretroviral agents for the treatment of HIV-1 infection," the release added.
